Startups channel feed – Endpoints News

Startups channel feed

Milestone Pharma grabs an $80M round as it steams into pivotal trial work, starts outlining commercial structure

7 years ago

Antisense startup Stoke Therapeutics secures another $90M in series B funding

7 years ago

Bain’s Adam Koppel commits $350M to launching a new biotech that is carving out Pfizer’s neuro pipeline

7 years ago

Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline

7 years ago

Biotech vets launch a neuro startup with $54.5M to kickstart R&D

7 years ago

Versant-backed Gotham Therapeutics launches with $54M round and a new way to connect on mRNA

7 years ago

MIT spinout from Sangeeta Bhatia’s lab gets a $22M round to develop new disease and drug sensors

7 years ago

GSK hands cash and tech to a biotech startup pointed down the same R&D road they want to travel

7 years ago

Gurnet Point-backed Boston Pharmaceuticals supercharges pipeline with twin deals grabbing top cast-offs from GSK, Novartis

7 years ago

F-Prime's Ben Auspitz co-leads $30M Series A with OrbiMed for his latest rare disease venture

7 years ago

Three years after selling Acerta to AstraZeneca in $7B deal, Dave Johnson is back at the helm of a biotech startup

7 years ago

Loyola is working on a new and improved CAR-T product, looking to overcome high-frequency side effects

7 years ago

Atlas, F-Prime provide launch money for Akrevia — a little biotech with big plans to design better drugs

7 years ago

Lyra pockets $29.5M to push ear, nose, throat applications of implant tech from Langer, Whitesides

7 years ago

Guest column: The 3 big waves reshaping investment strategies in early-stage biotech

7 years ago

An autoimmune upstart turns PD-L1 around to blaze a new approach to diabetes, multiple sclerosis

7 years ago

Ron DePinho raises seed cash for MD Anderson colleague's work on a 'Holy Grail molecule' in cancer, inflammation

7 years ago

With new $10.6B fund, Hillhouse Capital sets the stage for splashy Asia-focused biotech deals

7 years ago

Launch a new company, steer a $150M IPO and ink a big data collaboration — they call it Monday at Vivek Ramaswamy’s Roivant

7 years ago

Mike Narachi gets a $19M shot at a new approach to gene therapy — and he has another big market in mind

7 years ago

Focusing on the tumor microenvironment, OncoResponse garners $40 million for the next stage of the R&D journey

7 years ago

MPM, Novartis lead a big launch round for Kazumi Shiosaki’s latest biotech startup coming out of Harvard

7 years ago

Third Rock woos top Roche scientist Sanjay Keswani to the helm of biotech startup Rheos Medicines

7 years ago

An elite team of young, transpacific scientists out of Harvard and MIT starts plowing next-gen cell therapy tech field

7 years ago

First page Previous page 61 62 636465 66 67 Next page Last page